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ABSTRACT  
The reaction of amino acid derived N-carboxyanhydrides (NCAs) with unprotected amino acids 
under carefully controlled aqueous continuous flow conditions realized the formation of range of 
di- and tripeptide products in 60-85% conversion at productivities of up to 535 g.L-1h-1. This 
required a fundamental understanding of the physicochemical aspects of the reaction resulting in 
the design of a bespoke continuous stirred tank reactor (CSTR) with continuous solids addition, 
high shear mixing, automated pH control to avoid the use of buffer, and efficient heat removal to 
control the reaction at 1±1 °C. 
KEYWORDS 
Small Peptide; /HXFK¶V1&$; Water; Continuous flow CSTR; Process control 
 
INTRODUCTION 
Short peptides, that are composed of several amino acids, are important compounds within society 
with applications in medicine,1 farming,2 food,3 and materials,4 however their manufacture is both 
inefficient and unproductive.5, 6 0HUULILHOG¶VVROLG-phase-peptide-synthesis (SPPS) is remarkably 
predictable and used widely for making small quantities of complex peptides.7 However, the scale-
up of SPPS to make even kilograms of short peptides is difficult, being  characterised by: 
sequences of excess coupling reagents; protection-deprotection steps; dilute conditions with 
problematic organic solvents; addition and deletion sequences caused by physical issues with 
washing the resin, Scheme 1a and Table 2.8, 9  
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Scheme 1. Examples of dipeptide synthesis indicating atom economy in colored type, with waste 
and operations in black type. a. SPPS;9 b. SPS;10 c. Enzyme.11 
On the other hand, organic solution phase synthesis (SPS), that uses similar chemical methodology 
to SPPS, is the main method for small peptide manufacture. It also suffers poor green credentials: 
protecting groups, atom inefficiency, high E-factor and low process mass intensity, Scheme 1b, 
Table 2.12-14 Biosynthesis methods are leading the way in synthesis of longer peptides, for example 
in insulin manufacture,15 but are unproductive for short peptides. For example proteases are used 
to couple protected amino acids, but rely on high enzyme loadings and displacing unfavourable 
equilibria with either excess reagents, solubility effects or organic solvents, Scheme 1c.11, 16-22 
Surprisingly, the pioneering work done in the 1950-60s by Bartlett and Hirschmann describing the 
coupling of N-FDUER[\DQK\GULGH1&$RU/HXFK¶s anhydride) to amino acids has not been widely 
adopted, despite it being productive, cost effective and green, Scheme 2.23-27  
 
 
Scheme 2. The NCA method of peptide synthesis 
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All twenty amino acids have been tested with several NCAs, though some require side-chain 
protection, and 4g of a pentapeptide has been prepared in overall 27% yield, though the purity was 
not measured directly.24  A key enabler in this methodology is the use of water, which unlike 
organic solvents used in SPS is able to dissolve high concentrations of the free amino acids. In this 
article, we report studies to overcome the physico-chemical problems with the NCA methodology 
that appear to be a barrier to its exploitation, and initial development of a continuous process that 
enables precise control of the conditions and which required an unusual reactor design. This was 
used to produce a variety of di- and tripeptides in good conversion and high productivity, including 
an Aspartame derivative.28  
HirschPDQQ¶V1&$SURFHVVinvolves the batch reaction of D-amino carboxylates with solid NCAs 
under carefully determined aqueous conditions: pH 10.2, controlled using a 1M sodium borate 
buffer with 6M KOH addition; a temperature of 0 ࣙC maintained with ice.27 Control of these are 
important, otherwise side reactions occur that are exacerbated by the rapid formation of acid and 
a strong exotherm. Our studies found that at this temperature the sodium borate buffer precipitates, 
furthermore, addition of ice dilutes the reaction and causes problems with mixing. Accordingly, 
less buffer and spatially separate cooling are preferable. It has been observed that if the NCA is 
dissolved in a dry organic solvent and added to a solution of the amino acid, low yields occur as a 
result of side reactions.29 In this regard, Hirschmann recognized the need for high shear mixing to 
rapidly disperse the highly reactive solid NCA which, when added portion-wise into the best 
DYDLODEOHHTXLSPHQWD³:DULQJ´NLWFKHQEOHQGHULPSURYHGWKHVHOHFWLYLW\25 High shear mixing is 
used to reduce the depth of the static boundary layer on a particle, and is DIXQFWLRQRIWKH5H\QROG¶V
number, in particular the fluid velocity, particle shape and size, Figure 1.30  
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Figure 1. A model of the reactions occurring with NCA in the liquid boundary layer and bulk 
solution during dissolution of the solid.  
The amino acid needs to be brought rapidly into contact with the NCA to compete with its 
hydrolysis, also to neutralise the acid to prevent decarboxylation. Any CO2 that is generated is 
trapped by the base as carbonate. The reason that pH10.2 has been found to be optimal becomes 
clear: the NCA pKa is 11.3, so this pH keeps the reactive anion concentration low; whilst the 
amino acid pKa is 9.2, keeping the concentration of the free amine high. The reactivity of NCAs 
has been discussed in detail by Kricheldorf, and includes their use in the formation of 
homopolypeptides.31 Bartlett studied the kinetics of NCA hydrolysis and estimated the rate to be 
one third that of the amino acid at the same pH, both rates being above 1.6*106 M-1.s-1.32, 33 Caplow 
and Johnson each showed the intermediate carbamic acid is unstable above 0 ࣙC (a problem in 
water) and can prematurely decarboxylate to the free amino acid with a rate constant of >9* 107 
M-1.s-1 for glycine at pH10,34, 35 leading to an unwanted tripeptide, Figure 1. Hirschmann also 
proposed the formation of hydantoic acid side-products by decomposition of the NCA to 
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isocyanate, as well as NCA dimerization.26 These side reactions lead to impurities that are difficult 
to separate from the desired product, Figure 1, and it is clear that carrying out the reaction in batch 
makes control of the conditions difficult as others have observed.26 Previous reports of solution 
SKDVHSHSWLGHIRUPDWLRQLQIORZLQFOXGH.QXGVHQ¶VDXWRPDWHGVHTXHQFHVSHFLILFV\QWKHVLVZKHUH
Cbz protected NCAs formed in-situ are reacted with unprotected amino acids in DMF.36  Whilst 
achieving excellent yields for a range of peptides, the process is of low productivity, requires 
protecting groups and excess NCA that reduce the atom efficiency. Fuse et al. report the reaction 
of O-protected amino acids with N-protected amino acids activated by in-situ reaction with 
triphosgene,37 high yields are achieved with a 5 second residence time (Tres) over 2 steps, but with 
similar limitations in efficiency. Herein we describe initial studies to develop a continuous-mode 
YHUVLRQRI+LUVFKPDQQ¶VNCA process aimed at overcoming these limitations. 
 
RESULTS AND DISCUSSION 
Our study selected a single-stage CSTR in preference to a plug-flow reactor (PFR) which is 
incapable of providing solids addition, high intensity multiphase mixing, and pH control, Figure 
2. The size and shape of the reactor were defined by the equipment needed to operate the process. 
A problem with the single stage CSTR is that the residence time distribution (RTD) can be wide 
with material passing straight through or never emerging, use of a food dye marker indicated more 
than 4 reactor volumes were required. A multi-stage CSTR would give a more efficient process, 
however with the process limitations the complexity of such a system precluded this approach. 
The purpose-built reactor comprised: a stainless steel vessel with overflow tube to maintain 300 
mL volume; an automated powder dispenser to continuously dose the NCA (achieved with a 
variable speed, motor-driven, rotating angled pipe, accurate to 7 wt%, (SI, 7.2)); a high shear mixer 
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employed to promote rapid mixing of the reactants; an internal cooling-coil required to maintain 
the desired temperature of 0-2 ࣙC; pH probe and thermocouple. The heat from the mixer at 4000 
rpm along with 1.8 mL/min KOH caused the water temperature to rise at 0.85 ࣙC.min-1; and by 
difference, the reaction exotherm was found to be 0.54 ࣙC.min-1, 9.8 kJ.mol.-1min-1 (SI, Figure 1). 
In initial experiments, the amino acid was dissolved in sodium borate buffer at pH 10.2 and 
pumped at a rate stoichiometric with the continuously added, solid NCA,38 which defined the 
residence time by the overflow pipe. 
 
 
 
 
 
Figure 2. Diagram and photographs of the CSTR set-up used, showing high shear mixer, 
continuous solids addition system, internal cooling coil, and pumps. 
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The actual residence time was determined using a pulse of dye and found to be 8.6 minutes 
compared to 7 minutes theory, indicating only a small hold-up (SI 2.0). To achieve steady-state 2-
3 reactor volumes (one RV is 300 mL) were required, and residence times of 5, 7 and 14 minutes 
were evaluated to determine the optimum (SI 2.0); equating to 10-70g of NCA per experiment.  
Initial experiments employed commercially available L-Ala NCA which was reacted with L-Phe, 
to form L-Ala-L-Phe dipeptide.39 Since litres of aqueous product were generated in each 
experiment, the amino acid to dipeptide conversion was measured by sampling the acid quenched 
solutions, and determining the amino acid and peptide concentrations against authentic standards 
by 1HNMR, HPLC and LCMS. The instability of the NCA meant that its conversion to dipeptide 
could not be measured directly. Figure 3 shows the importance of mixing, measured as mixer speed 
vs. conversion. 
 
 
 
 
  
 
 
 
 
 
Figure 3. Reaction conditions and the effect of mixer speed on dipeptide formation 
Using a residence time of 7 min, 3*300 mL reactor volumes were collected at each speed. At 1200 
rpm product formation was low and inconsistent with the solid NCA building-up on the surface 
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(ESI Figure 4). Above 3000 rpm, 70% of the crude dipeptide was produced with little variation at 
steady-state, and 4000 rpm was selected for subsequent reactions. The reaction stoichiometry is 
important since it was found that 1.5 eq. of NCA led to over-reaction, with tripeptide and other 
side-products formed, whilst an undercharge caused problems with amino acid and dipeptide 
separation; all subsequent experiments used 1.1 eq. of NCA (ESI Figure 5). Table 1 shows the 
results of varying other reaction parameters.  
Table 1. Optimization of reaction conditions for L-Ala-L-Phe formation.  
Entry[a] [Na2B4O7]aq. (M)
[b] Achieved 
pH[c] 
Achieved 
temp. (ࣙC) 
% Dipeptide in 
crude reaction 
product [d] 
1 0.4 9.9-10.3 -1.3-2.7 51 
2 0.1 10-10.35 1.7-3.1 63 
3 0.1 8.8-9.2[e] 0.8-2.2 51 
4 0.1 10.8-11.3[f] 0.0-3.3 70 
5[g] 0.1 9.6-10.3 0.5-4.0 72 
6 None 9.5-10.5 0.6-1.7 68 
7[h] 0.1 9.9-10.5 4.2-6.4 39 
8 None 10-10.6[i] 2.0-4.6 58 
9 None 10.2-10.4[j] 0.5-3.7 33 
10[g][k] 0.1 10.1-10.2 3.3-5.6 61 
11[l] 0.1 9.8-10.2 0.9-1.5 67 
12[k][l] 0.1 9.9-10.4 1.0-2.1 71 
 [a] Tres = 7 min. [b] With 0.2M amino acid initially at pH 10.2. [c] Manual addition of 6M KOH 
to target pH 10.2 [d] Calculated from the 1HNMR ratio of dipeptide : amino acid + dipeptide + 
tripeptide.[e] target pH 9 [f]  target pH 11. [g] Tres = 5 min. [h] NCA added as 0.22 M solution in 
THF. [i] Et3N used to control pH. [j] NH4OH used to control pH. [k] L-Ala NCA reacted with L-
Leu. [l] Tres = 14 min. 
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Whilst 0.4 M sodium borate buffer solution enabled control of pH 10.2, its poor solubility at 0-2 
ࣙC lead to difficulties in maintaining constant addition (Entry 1). A lower buffer strength (Entry 
2), or no buffer (Entry 6), gave an increase in dipeptide; however relying on manual KOH addition 
made it difficult to maintain a constant pH, Figure 4. 
 
 
 
 
 
 
 
Figure 4. pH control of dipeptide formation with and without pH controller. With manual pH 
control the KOH flow rate was adjusted by hand to maintain pH 10.2.  
 
Table 1 Entry 3 shows that at pH 8.8-9.2, 20% less product is produced, whilst a higher pH of up 
to 11.3, was less problematic (Entry 4). Increasing the amino acid feed-rate, to reduce the residence 
time from 7 to 5 minutes, resulted in poor temperature control, reaching 4 ࣙC (Entry 5) and 5.6 ࣙC 
(Entry 10) because of the increased energy required to cool the ambient temperature amino acid 
feed. Increasing the Tres from 5 to 7 to 14 minutes, at similar pH and temperature ranges, changed 
little the steady-state conversions of 70%, 72%, 67%, (Entries 4, 5, 11) indicating the reactions 
were complete even at the shortest time. On the other hand, the reaction of L-Ala NCA and L-Leu, 
with residence times of 5 and 14 minutes, improved the conversion from 61% to 71%, that might 
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indicate a slower reaction or reduced mass transfer (Entries 10 and 12). The addition of L-Ala 
NCA dissolved in THF gave a significantly lower yield, 39% compared to 72% with solid addition, 
confirming previous studies.27, 29 The use of aqueous triethylamine or ammonia instead of KOH, 
gave lower yields with reduced thermal control and, in the case of the latter, a major new side-
product, alanine amide (Entries 8 and 9).40 It is interesting to note that the overall quantity of 
hydroxide required to maintain the reaction at pH10.2 was found to be 1.61 equivalents relative to 
the amino acid (See ESI, Section 1). The titration stoichiometry can be rationalised by considering 
the 72% conversion of L-Phe and L-Ala NCA to L-Phe-L-Ala (Entry 5), that consumes 0.72 
equivalents of base. Since 1.15 equivalents of NCA are added, this means 0.43 equivalents of base 
are used in hydrolysis, and the remaining 0.46 probably react with the CO2 resulting from 
carbamate decarboxylation, to form a 1:2 mixture of potassium bicarbonate and carbonate giving 
it a pKa of 10.6 in this salt solution compared with the literature pKa of 10.3 in pure water.41 Based 
on this, 63% of the NCA forms dipeptide product and 37% is hydrolysed. The close correlation 
EHWZHHQFDOFXODWHGDQGWKHRU\VWRLFKLRPHWU\FRQILUPV%DUWOHWW¶VREVHUYDWLRQWKDWWKHUHODWLYHUDWH
of peptide formation is twice that of the NCA hydrolysis, but also indicates that the side reactions 
are difficult to suppress.  
Isolation of small quantities of the products analysed by HPLC and 1HNMR showed no evidence 
of racemisation, and this is supported by reports in the literature.25, 37 For purification and isolation, 
Hirshmann et al. report the use of chromatography with ion exchange resins, silica gel or carbon 
as the stationary phase, depending on the peptide. In our hands, ion exchange chromatography was 
successful in separating the salts from the reaction solution, but did not usefully separate the 
unreacted amino acid from the desired dipeptide. For reactions carried out without buffer, silica 
gel chromatographic purification was possible and gave the desired dipeptide cleanly for L-Ala-
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L-Phe, and in enhanced purity for L-Val-L-Phe. All products, whether prepared with or without 
the presence of the buffer, could also be isolated cleanly on a small scale by use of mass directed 
preparative chromatography. Tripeptides could not be isolated in this way.  
The defined process conditions and controls were then used to further explore the reaction scope, 
Figure 5.  
 
 
 
 
 
 
 
 
 
Conversions calculated from the 1HNMR ratios [a] Dipeptide starting material was 1.3 M crude 
solution from the L-Ala-L-Phe reaction. [b] Conversion given for dipeptide to tripeptide 
transformation. [c] Dipeptide starting material was 0.17 M solution 
Figure 5. Peptide products synthesized, molar conversions (product / amino acid) and 
productivities. 
 
L-Ala and L-Val NCAs were reacted with L-Phe and L-Leu amino acids and gave 71-73% 
conversions, with productivities up to 330 g.L-1.h-1 and unisolated dipeptide masses of 43-58g 
which is remarkable when compared with either SPPS or organic phase SPS. The dipeptides were 
then used directly as 1.3 M and 0.17 M pH 10.2 solutions and fed into the next reaction with L-
Ala and L-Val NCA respectively. The L-Ala-L-Ala-L-Phe tripeptide was produced in this step 
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with 60% conversion and at 205 g.L-1.h-1 which over 5RV equates to 36g, whilst L-Val-L-Ala-L-
Leu was formed in 85% conversion at 285 g.L-1.h-1, giving 50g of the tripeptide in solution, Figure 
5. 
These results show that the conversions and productivities depend upon the type of NCA and 
amino acids and further improvement might be achieved by optimizing each reaction separately. 
In the meantime, it was decided to make a more interesting tri-peptide and we chose to make an 
Aspartame derivative as the L-Asp-L-Phe-OMe dipeptide ester is inexpensive and commercially 
available in large quantities. After hydrolysing the methyl ester to give L-Asp-L-Phe it was fed 
continuously into the CSTR along with L-Val NCA. With good control of pH and temperature and 
based on 1HNMR integration of a sample, the tripeptide was produced at steady-state in 66% 
conversion and at a rate of 535 g.L-1.h-1, providing over 5RV 94g. The 1NMR spectrum showed 
29% L-Asp-L-Phe starting material and therefore only 5% other impurities.         
Presently, the difficulty in preparing longer peptides is the need to separate them from large 
quantities of aqueous salt solutions. The small-scale purifications using ion exchange and silica 
demonstrate the potential for larger scale; and since the main separation is binary (i.e. amino acid 
from dipeptide), continuous purification by simulated moving bed chromatography may be an 
option. Further work is looking at the use of membranes and affinity tags. The system is currently 
limited by the need for solid addition, the size of mixer and of the reactor, miniaturisation of this 
would allow a shorter residence time and fewer side-reactions. If quantitative conversion of 
reagents to the desired product could be achieved this would negate the need for intermediate 
purifications. 
The sodium borate buffer not only poses health risks but is a significant part of the process waste. 
An automated pH controller was constructed in-house to allow rapid measurement and adjustment 
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of pH. The unit is a proportional integral controller built on an embedded electronic circuit and 
tuned for this application (see ESI). The controller is connected to a pH probe within the reaction 
solution and to a peristaltic pump with 6M KOH (aq). Figure 4 shows a comparison of manual and 
automated pH control for formation of a dipeptide without the use of sodium borate buffer. For 
manual pH control, the pH varies by 1 pH unit during the reaction, whereas with automated pH 
control the variation is 0.2 pH units. The conversion to product is comparable for both methods, 
however the pH controller allows more efficient use of KOH. The continuous process, with 
automated pH control allowing the removal of the buffer from the reaction not only offers high 
productivity and efficiency, but also avoids safety considerations and significantly reduces the 
chemical mass intensity of the process.  
A particular focus of the study was to develop a method with improved environmental 
performance, so metrics of related continuous and batch processes were compared, Table 2.42  
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Table 2. Comparison of reaction metrics for formation of dipeptide. [a] 
[a] for calculations see ESI [b] based on reference 26  [c] estimated from reported tetrapeptide 
synthesis reference 9 [d] by HPLC. 
 
Since there is no reported procedure for making the identical peptides, we based it as fairly as 
SRVVLEOH RQ 0HUULILHOG¶V 6336 GHVFULSWLRQ RI RQH VWDJH LQ PDNLQJ D WHWUDSHSWLGH DQG WKDW RI
+LUVKPDQQ¶V/-Phe-L-Ala in batch.9 Comparing the SPPS and flow NCA method the latter gave 
a higher steady-state conversion of 82%, (Entry 1) and was 4600 times more productive (Entry 2), 
with the total mass intensity which includes solvent, a hundred-fold better (Entry 3). Reaction mass 
efficiency is the reciprocal of E-factor and considers atom economy, yield and stoichiometry, and 
this is 67% compared to 4% for the SPPS process (Entry 4). Unsurprisingly without protecting 
groups, the batch and flow NCA methods have much superior atom economies than SPPS (Entry 
5). Meanwhile comparing the batch and flow NCA processes, the latter is 173-times more 
Entry Metric SPPS NCA method 
(batch)[b]  
This study: 
un-buffered 
(continuous) 
 Peptide L-Leu-L-Ala[c] L-Ala-L-Phe L-Val-L-Phe 
1 Yield (%) 50 70 82[d] 
2 STY (g.L-1h-1) 0.014 0.35 60.5 
3 Total PMI 3165 686 28 
4 RME (%) 4 57 67 
5 AE (%) 10 84 86 
6 Health & Safety  DMF Na2B4O7 None 
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productive (Entry 1), and has a total mass intensity 24-times better (Entry 2), mainly due to the 
avoidance of borate buffer which also improves health-safety aspects (Entry 6). 
 
CONCLUSIONS 
A continuous flow stirred tank reactor has been carefully designed to control within a narrow 
range, operating conditions that favour the reaction of NCA with amino acid, and minimise side 
reactions that produce impurities that are difficult to separate. The use of a cooling coil inside the 
reactor removes both the reaction exotherm and heat generated from the mixer to maintain the 
optimal of 0-2oC. This temperature range is important in lowering the rate of side-reactions relative 
to the desired reaction. The need for intense, high shear mixing has been shown to improve amino 
acid conversion to the product. This facilitates the rapid dispersion of solid NCA and concentrated 
hydroxide that is added to neutralise the acid produced in the reaction, that otherwise leads to 
product decarboxylation. Since the reactions in the system are very fast, they are likely to take 
place near the surface of the NCA particle, and high shear mixing reduces the size of boundary 
layer to facilitate transport with the bulk liquid. Automated continuous addition of NCA solid at a 
defined and consistent rate allowed the maintenance of the optimal 0.1 equiv. excess over the co-
fed pH10.2 amino acid solution. Nevertheless, with these fast reactions precise control of 
stoichiometry may still be problematic. Whilst the L-Ala NCA fine white particulate material was 
well behaved (ensuring exclusion of moisture), the L-Val NCA particles were more cohesive, 
requiring regular tapping of the hopper, and making its addition less consistent. Clearly, the 
material properties of other NCAs may affect the ease with which they can be added. Consideration 
of the base stoichiometry shows the relative rates of NCA reaction with amino acid to base 
hydrolysis are about 2:1. Based on steady-state hydroxide and amino acid concentrations of 
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0.16mM and 0.1M, and assuming both reactions are first order in NCA, the rate constant for the 
reaction with hydroxide is 373 times that of the amino acid. Minimising hydrolysis is difficult, 
however if the amino acid and NCA concentrations were increased to 1M at the same hydroxide 
concentration, the dipeptide yield might be improved to 94%.43 This would require more rapid 
addition of more material and would test the physical boundaries of the system, indicating that 
further improvements to the reactor design would be necessary.   
Further work is required to determine the optimal residence time, and as the studies indicate this 
may vary for individual NCA and amino acid/peptide reactions. The fast reaction makes it possible 
to maintain a high conversion with a shorter residence time, eg. <1 minute, and this would alleviate 
further reaction of the product; a smaller volume multi-stage CSTR would improve the efficiency, 
however the need to add solids makes this difficult.44 A homogenous reaction would considerably 
simplify the equipment and this approach is currently being investigated. 
The productivity of the continuous process is much higher than other methods, and this could help 
reduce the costs of peptide production,45, 46 however a current problem is isolation of the peptides 
from large volumes of salt solutions. Work to develop continuous membrane separation and 
purification processes is ongoing. Realistically the flow NCA method is likely to be limited to 
tetra- or pentapeptides, but these might coupled by block condensation to form longer chain 
peptides.47  
The continuous flow synthesis of a series of di- and tri-peptides has been achieved through 
understanding the chemical and physical requirements of the reaction and this information used to 
design a multi-phasic flow reactor that minimises unwanted side-reactions. The concept of 
designing a reactor to meet the physicochemical requirements of a reaction can applied to other 
complex systems. A further useful aspect described here is the use of rapid and precise pH control 
 18 
to avoid the use of a buffer thereby improving the green metrics of for example biocatalysed 
reactions. 
 
EXPERIMENTAL 
Commercially available chemicals used in this work were obtained from Sigma Aldrich and 
Fluorochem of reagent or reagent plus grade. L-Alanyl NCA and L-valyl NCA were obtained from 
Isochem and were stored under N2 at -20 ࣙC. NMR: Bruker DPX-300 (300 MHz), Bruker Ascend 
400 (400 MHz) or Bruker DRX-500 (500 MHz) instruments using D2O solvent. The HPLC 
employed an Agilent 1100 Series HPLC with Chemstation software for processing. LCMS was 
carried out using a Bruker HCT Ion trap mass spectrometer coupled with Agilent 1100 HPLC. 
HRMS was done with a Bruker Maxis Impact spectrometer with Ultimate 3000 UPLC. IR spectra 
were determined using a Bruker ALPHA FT-IR spectrometer. Melting points (Mp) with Stuart 
Melting Point Aparatus SMP30. Optical rotations were determined with a Schmidt and Haensch 
Polartronic H 352 with 1 dm cell. Mass Directed Automated preparative chromatography (MDAP) 
was done using Agilent Technologies 2120 Quadrupole mass spectrometer with Agilent 
Technologies 1260 Infinity HPLC.  
A detailed description of the continuous flow equipment built and used in the study is shown in 
photos, diagrams and described in the ESI Section 7.3. The overflow pipe in the reactor was set at 
the 300 mL level. To the reactor was added 300 mL of the reaction solvent (0.1M Na2B4O7 aq. or 
water/base) and the pH was adjusted to pH10.2 by addition of base as necessary. The solvent was 
stirred (4000 rpm) and cooled to 0 °C. Once at 0°C, to the reactor was then fed 0.2 M, pH 10.2 
aqueous amino acid solution (41 mL/min, 8.2 mmol/min.), the required NCA (9 mmol/min.) and 
base, if required, at a rate necessary to maintain the reaction solution at pH 10.2. The reaction was 
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stirred at 4000 rpm and the temperature maintained between 0-2 °C. The reaction solution was 
collected via the overflow pipe. During the reaction, the reaction temperature, pH and flow rate of 
base were recorded each minute. After 7 min. (1 residence time), 300 mL (1 reactor volume) of 
solution had been collected. The collection vessel was replaced and the process repeated until the 
required number of reactor volumes had been collected. Once collected, each reactor volume was 
acidified with 3M sulfuric acid to allow decarboxylation of the carbamate intermediate. The 
products from each individual reactor volume were analysed by NMR and HPLC. For NMR, 1 
mL of the reaction solution was dried by rotary evaporation and a portion of the solid was dissolved 
in D2O. For the initial reactions, a known mass of NaOAc was added to the NMR sample as an 
external standard however results from this were found to be inconsistent and were not used 
further. For HPLC, ȝ/RIWKHUHDFWLRQVROXWLRQZDVDGGHGWRȝ/RI 0.1M biphenyl in MeOH 
(external standard). To this waVDGGHGȝ/0H2+DQGȝ/+2O. Grace Davidson Vydac 
&73[PPSRUHVL]HcSDUWLFOHVL]HȝPS+-7.5; 210 nm; 25 °C column 
RYHQȝ/LQMHFWLRQYROXPHP/PLQVROYHQW$ Water + 0.1% TFA; solvent B: MeCN + 
0.1% TFA; Gradient: 0 min 5% B, 16 min 40% B, 18 min 40% B, 20 min 80% B, 27 min 80% B, 
28 min 5% B. The retention times of amino acids and peptides were: L-Phenylalanine: 7.2 min; L-
Alanyl-L-phenylalanine: 8.9 min; DL-Alanyl-DL-phenylalanine: 8.9 and 10.6 min; L-Alanyl-L-
alanyl-L-phenylalanine: 14.0 min; L-Valyl-L-phenylalanine: 14.7 min; L-Alanyl-L-leucine: 10.2 
min; L-Leucine: 7.0 min; L-Valyl-L-alanyl-L-leucine: 17.3; L-Valyl-L-aspartyl-L-phenylalanine: 
18.0 min; L-aspartame: 16.2 min; Biphenyl (external standard): 25.7 min.  
Purification was carried out by mass directed auto preparative chromatography (MDAP) or ion 
exchange and flash chromatography. For the former technique, small quantities (5-10 mL) of the 
crude reaction solutions were purified to give samples of the desired reaction products for 
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characterisation and to act as HPLC standards (see ESI Section 4.5 Peptide products). The MDAP 
method employed an Xbridge Prep C18 ȝP2%'TM 19x100 mm. 5-95% MeOH in water with 
0.1% formic acid over 8 min., 20 mL/min flow rate. Purification by ion exchange chromatography 
was done using Dowex 50WX4 100-200 mesh ion exchange resin prewashed with water.  20 mL 
of the crude reaction solution was basified to pH 5.5 with 1 M KOH aq. and loaded onto the 
column. The products were eluted with firstly a pH 5.5 aqueous solution, followed by pH 5.7 and 
finally pH 6. The fractions collected were analysed by TLC (Si gel, CHCl3: MeOH: NH4OH 18% 
aq. 50:40:10, visualisation by UV and PMA dip.) This method was found to successfully remove 
salts and tri-, tetra- peptide side products from buffer free reactions. In the reaction to form L-
Alanyl-L-Phenylalanine, the dipeptide was successfully separated from residual phenylalanine 
starting material by this method alone, whilst for the other dipeptides this was not possible and 
subsequent silica gel flash chromatography was required. This was carried out by loading the 
concentrated dipeptide/amino acid mixture onto the silica gel column. The products were then 
eluted with DCM: MeOH: NH4OH aq. 18% 30:60:10. The fractions were analysed by TLC using 
the same solvent system, and visualised by UV and PMA dip. For L-Val-L-Phe preparation, the 
dipeptide was obtained as an enriched mixture along with less phenylalanine than by ion exchange 
chromatography alone. 
Characterisation data for the products is as follows. 
L-Alanyl-L-Phenylalanine. Mp 242-243ࣙ&>Į@D20 +39.3 (589 nm, c 2, water) (lit.48 >Į@D25 + 38.8 
(L,L,5Ȟmax 3229.8, 2923.7, 1668.0, 1522.6, 1222.5, 1076.8, 739.4, 697.5, 608.7 cm-1; 1H NMR 
(500 MHz, D2O) 
1+1050+]'HXWHULXP2[LGHįWJ = 7.3 Hz, 3H, CHAr), 7.38 ± 
7.31 (m, 4H, CHAr), 4.65 (dd, J = 8.9, 5.6 Hz, 1H, CHCH2Ar), 4.03 (q, J = 7.1 Hz, 2H, CHCH3), 
3.29 (dd, J = 14.0, 5.6 Hz, 1H, CHaHbAr), 3.09 (dd, J = 14.1, 9.0 Hz, 2H, CHaHbAr), 1.53 (d, J = 
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7.1 Hz, 3H, CH3); 
13C NMR (125 MHz, D2O) 175.78 (C=O), 170.37 (C=O), 137.11 (CiHAr), 
129.30 (2 x CoHAr), 128.83 (2 x CmHAr), 127.19 (CpHAr), 55.36 (CHCH2), 49.01 (CHCH3), 36.78 
(CH2), 16.49 (CH3); LRMS m/z (ESI) 237.3 (M
+ + H); HRMS m/z (ESI): M+ + H, 237.12342 
C12H17N2O3 requires M 237.12337. 
L-Alanyl-L-Leucine. Mp 226-227ࣙ&>Į@D20 -30.2 (589 nm, c ZDWHU,5Ȟmax 3218.1, 3067.3, 
2956.8, 1667.4, 1520.7, 1049.5, 606.6 cm-1; 1H NMR (500 MHz, D22įWJ=7.3 Hz, 1H, 
CHCH2CH(CH3)2), 4.15 (q, J=7.1 Hz, 1H, CHCH3), 1.73-1.72 (m, 3H, CH2 and CH(CH3)2 
overlapping), 1.60 (d, J=7.0 Hz, 3H, CH3), 0.97 (dd, J=17.8, 6.3 Hz, 6H, CH(CH3)2); 
13C NMR 
(125 MHz, D2O) 176.82 (C=O), 170.85 (C=O), 52.20 (CHCH2(CH3)2), 49.02 (CHCH3), 39.41 
(CH2), 24.57 (CH(CH3)2, 22.22 (CH3), 20.72 (CH3), 16.57 (CH3); LRMS m/z (ESI) 203.4 (M
+ + 
H); HRMS m/z (ESI): M+ + H, 203.13897 C9H19N2O3 requires M 203.13902. 
L-Valyl-L-Phenylalanine. Mp 233-234ࣙ&>Į@D20 +70 (589 nm, c ZDWHU,5Ȟmax 3218.1, 3067.3, 
2956.8, 1667.4, 1520.7, 1049.5, 606.6 cm-1; 1H NMR (500 MHz, D22į-7.41 (m, 2H, CHAr), 
7.38 ± 7.35 (m, 3H, CHAr), 4.67 (dd, J = 8.6 Hz, 1H, CHCH2Ar), 3.80 (d, J = 5.6 Hz, 1H, 
CHCH(CH3)2), 3.27 (dd, J = 14.1, 5.8 Hz, 1H,  CH
aHbAr), 3.10 (dd, J = 14.1, 8.7 Hz, 1H, 
CHaHbAr), 2.28 ± 2.18 (m, 1H, CH(CH3)2), 1.05 ± 1.01 (m, 6H, (CH3)2); 13C NMR (125 MHz, 
D2O) 175.78 (C=O), 168.93 (C=O), 137.07 (CiHAr), 129.29 (2 x CoHAr), 128.85 (2 x CmHAr), 
127.20 (CpHAr), 58.50 (CHCH2CH(CH3)2), 55.54 (CHCH(CH3)2), 36.88 (CH2), 30.09 
(CH(CH3)2), 17.69 (CH3CHCH3), 16.69 (CH3CHCH3); LRMS m/z (ESI) 265.3 (M
+ + H); HRMS 
m/z (ESI): M+ + H, 265.15510 C14H21N2O3 requires M 265.15467. 
L-Alanyl-L-Alanyl-L-Phenylalanine. Mp 209-210 ࣙ&>Į@D20 -13.6 (589 nm, c ZDWHU,5Ȟmax 
3261.8, 3063.9, 2935.8, 1632.8, 1529.9, 1077.7, 958.5, 696.5, 575.8 cm-1; 1H NMR (500 MHz, 
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D22į-7.30 (m, 2H, CHAr), 4.63-4.54 (m, 1H, CHCH2Ar), 4.34 (q, J = 7.2 Hz, 1H, CHCH3), 
4.08 (q, J = 7.1 Hz, 1H, CHCH3), 3.24 (dd, J = 13.8, 5.4 Hz, 1H, CH
aHbAr), 3.08 (dd, J = 13.8, 
7.9 Hz, 1H, CHaHbAr), 1.51 (d, J = 7.0 Hz, 3H, CH3), 1.37 (d, J = 7.1 Hz, 3H, CH3); 
13C NMR 
(125 MHz, D2O) 176.13 (C=O), 173.87 (C=O), 170.50 (C=O), 137.00 (CiHAr), 129.47 (2 x 
CoHAr), 128.74 (2 x CmHAr), 127.10 (CpHAr), 55.13 (CHCH2Ar), 49.82 (CHCH3), 49.00 
(CHCH3), 37.17 (CH2), 16.69 (CH3), 16.65 (CH3); LRMS m/z (ESI) 308.4 (M
+ + H); HRMS m/z 
(ESI): M+ + H, 308.16069 C15H22N3O4 requires M 308.16048. 
L-Valyl-L-Alanyl-L-Leucine. Mp 341-342 ࣙ&>Į@D20 -93.4 (589 nm, c ZDWHU,5Ȟmax 3295.1, 
3065.6, 2961.1, 1644.7, 1541.2, 1232.1, 1160.8, 1044.2, 605.1 cm-1; 1H NMR (500 MHz, D2O) 
į T J = 7.2 Hz, 1H, CHCH3), 4.41-4.35 (m, 1H, CHCH2), 3.85 (d, J = 5.9 Hz, 1H, 
CHCH(CH3)2), 2.30-2.21 (m, 1H, CH(CH3)2), 1.74-1.69 (m, 3H, CH2 and CH(CH3)2 overlapping), 
1.45 (d, J = 7.2 Hz, 3H, CH3), 1.08-1.06 (m, 6H, (CH3)2, 0.98 (d, J = 6.3 Hz, 3H, (CH3)2, 0.93 (d, 
J = 6.3 Hz, 3H, (CH3)2); 
13C NMR (125 MHz, D2O) 177.11 (C=O), 174.27 (C=O), 168.89 (C=O), 
58.45 (CHCH(CH3)2), 52.04 (CHCH2(CH3)2), 49.58 (CHCH3), 39.69 (CH2), 30.10 
(CH2CH(CH3)2), 24.52 (CHCH(CH3)2), 22.32 (CH3), 20.71 (CH3), 17.65 (CH3), 16.94 (CH3), 
16.50 (CH3); LRMS m/z (ESI) 302.4 (M
+ + H); HRMS m/z (ESI): M+ + H, 302.20749 C14H28N3O4 
requires M 302.20743. 
L-Valyl-L-Aspartyl-L-Phenylalanine. Mp 184-186 ࣙ&>Į@D20 -5.6 (589 nm, c ZDWHU ,5Ȟmax 
3193.3, 3066.0, 1713.8, 1660.3, 1517.5 1030.3, 581.8 cm-1; 1H NMR (500 MHz, D22į-7.14 
(m, 5H, CHAr in tripeptide and 2H CHAr in impurity), 4.69-4.67 (m, 1H, CHCH2CO2H), 4.49 
(dd, J = 8.0, 5.3 Hz, CHCH2Ar), 4.40-4.38 (m, 0.4H, impurity), 4.14-4.12 (m, 0.4H, impurity), 
3.69 (d, J = 5.9 Hz, 1H, CHCH(CH3)2), 3.16 (ddd, J = 38.2, 13.8, 4.6 Hz, 1.4H, CH
aHbCO2H and 
impurity), 2.98-2.95 (m, 1.4H, CHaHbCO2H and impurity), 2.77 (dd, J = 16.7, 5.0 Hz, 1H, 
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CHaHbAr), 2.64 (dd, J = 16.8, 8.8 Hz, 1H, CHaHbAr), 2.10-2.07 (m, 0.5H, impurity), 2.04-1.99 
(m, 1H, CH(CH3)2), 0.85 (t, J = xx Hz, 6H, CH(CH3)2); 
13C NMR (125 MHz, D2O) Complex 
spectra obtained due to unidentified impurity. Peaks could not be assigned; LRMS m/z (ESI) 380.4 
(M+ + H); HRMS m/z (ESI): M+ + H, 380.18241 C18H26N3O6 requires M 380.18161. 
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